AU2011307691A1 - Peptides from the venom of the Rhopalurus junceus scorpion and pharmaceutical composition - Google Patents

Peptides from the venom of the Rhopalurus junceus scorpion and pharmaceutical composition Download PDF

Info

Publication number
AU2011307691A1
AU2011307691A1 AU2011307691A AU2011307691A AU2011307691A1 AU 2011307691 A1 AU2011307691 A1 AU 2011307691A1 AU 2011307691 A AU2011307691 A AU 2011307691A AU 2011307691 A AU2011307691 A AU 2011307691A AU 2011307691 A1 AU2011307691 A1 AU 2011307691A1
Authority
AU
Australia
Prior art keywords
venom
junceus
scorpion
tumor
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011307691A
Other languages
English (en)
Inventor
Alexis Diaz Garcia
Jose Antonio Fraga Castro
Isbel Gonzalez Marrero
Irania Guevara Orellana
Regla Maria Medina Gali
Maria Regla Perez Capote
Yanelis Riquenes Garlobo
Judith Rodriguez Coipel
Caridad Clara Rodriguez Torres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRUPO EMPRESARIAL DE PRODUCCIONES BIOFARMACEUTICAS Y QUIMICAS
Original Assignee
Grupo Empresarial De Producciones Biofarmaceuticas Y Quim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grupo Empresarial De Producciones Biofarmaceuticas Y Quim filed Critical Grupo Empresarial De Producciones Biofarmaceuticas Y Quim
Publication of AU2011307691A1 publication Critical patent/AU2011307691A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2011307691A 2010-09-27 2011-09-27 Peptides from the venom of the Rhopalurus junceus scorpion and pharmaceutical composition Abandoned AU2011307691A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2010000186A CU24055B1 (es) 2010-09-27 2010-09-27 Composiciones farmacéuticas de veneno de escorpión rhopalurus junceus
CU2010-0186 2010-09-27
PCT/CU2011/000006 WO2012041261A2 (es) 2010-09-27 2011-09-27 Peptidos del veneno de escorpion rhopalorus junceus y composicion farmaceutica

Publications (1)

Publication Number Publication Date
AU2011307691A1 true AU2011307691A1 (en) 2013-05-02

Family

ID=45566782

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011307691A Abandoned AU2011307691A1 (en) 2010-09-27 2011-09-27 Peptides from the venom of the Rhopalurus junceus scorpion and pharmaceutical composition

Country Status (17)

Country Link
EP (1) EP2623111A2 (enExample)
JP (1) JP2013542196A (enExample)
KR (1) KR20140041381A (enExample)
CN (1) CN103200951A (enExample)
AP (1) AP2013006811A0 (enExample)
AR (1) AR083117A1 (enExample)
AU (1) AU2011307691A1 (enExample)
BR (1) BR112013007198A2 (enExample)
CA (1) CA2812841A1 (enExample)
CO (1) CO6781464A2 (enExample)
CU (1) CU24055B1 (enExample)
EC (1) ECSP13012595A (enExample)
IL (1) IL225577A0 (enExample)
MX (1) MX360726B (enExample)
RU (1) RU2563348C2 (enExample)
SG (1) SG191708A1 (enExample)
WO (1) WO2012041261A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103074304B (zh) * 2013-01-28 2016-01-13 江苏健安生物科技有限公司 高水平人二倍体细胞培养水痘-带状疱疹疫苗病毒方法
MX2019000570A (es) * 2018-12-19 2020-08-13 Centro De Investig Biologicas Del Noroeste S C Composición homeopatica a base de veneno de escorpión rhopalurus junceus y su uso en acuicultura.
AU2021408143A1 (en) * 2020-12-22 2023-07-27 PreveCeutical Medical Inc. Cyclic peptides and uses thereof
CN113384682B (zh) * 2021-05-31 2023-07-04 南方医科大学 蝎毒多肽Smp43在制备抗肿瘤药物的应用
CN117069800B (zh) * 2023-10-16 2023-12-12 山东省食品药品检验研究院 一种鉴别东亚钳蝎的特征多肽及其应用
WO2025241040A1 (es) * 2024-05-24 2025-11-27 Blue Scorpion Group Inc Péptidos derivados de veneno de escorpión heteroctenus junceus, sus variantes, composiciones, métodos y usos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030229C (zh) 1991-12-16 1995-11-08 山东省蒙阴县酒厂 全蝎酒的制作方法
CN1076858A (zh) 1993-03-24 1993-10-06 王强华 熊胆全蝎酒及其制备工艺
CU22413A1 (es) 1994-01-11 1996-01-31 Composicion antitumoral
US5905027A (en) 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
FR2745004B1 (fr) * 1996-02-16 1998-03-27 Rhone Poulenc Agrochimie Peptide antibacterien et antifongique
US6168651B1 (en) 1998-10-08 2001-01-02 Donaldson Company, Inc. Filter assembly with shaped adsorbent article; and devices and methods of use
CN1279088A (zh) 1999-06-25 2001-01-10 谷令旗 一种治疗肝癌药剂的制备方法
CN1265901A (zh) 2000-01-26 2000-09-13 徐忠廷 一种抗癌中药丸剂
CN1316249A (zh) 2001-04-04 2001-10-10 李滋星 全蝎活性营养液
CN1157215C (zh) 2001-07-30 2004-07-14 张官锁 一种治疗癌症的中药组合物
CN1325514C (zh) * 2001-09-30 2007-07-11 沈阳药科大学 蝎镇痛抗肿瘤缬精甘肽及获得方法
CN100465272C (zh) * 2002-01-18 2009-03-04 中国科学院上海有机化学研究所 重组东亚马氏钳蝎毒rBmKaIT1的基因工程
CA2487425A1 (en) * 2002-05-31 2003-12-11 Transmolecular, Inc. Combination chemotherapy with chlorotoxin
CN1256971C (zh) 2002-08-12 2006-05-24 徐继康 一种用于治疗肿瘤的中药胶囊
US8097284B2 (en) * 2007-11-13 2012-01-17 Arthur Mikaelian Polarized scorpion venom solution and a method for making polarized scorpion venom solution

Also Published As

Publication number Publication date
CU20100186A7 (es) 2012-06-21
RU2013119431A (ru) 2014-11-10
MX360726B (es) 2018-11-13
CO6781464A2 (es) 2013-10-31
WO2012041261A2 (es) 2012-04-05
SG191708A1 (en) 2013-08-30
IL225577A0 (en) 2013-06-27
AP2013006811A0 (en) 2013-04-30
CU24055B1 (es) 2014-12-26
KR20140041381A (ko) 2014-04-04
CA2812841A1 (en) 2012-04-05
CN103200951A (zh) 2013-07-10
WO2012041261A3 (es) 2012-11-22
JP2013542196A (ja) 2013-11-21
MX2013003545A (es) 2013-11-04
AR083117A1 (es) 2013-01-30
ECSP13012595A (es) 2014-11-28
RU2563348C2 (ru) 2015-09-20
BR112013007198A2 (pt) 2016-06-14
EP2623111A2 (en) 2013-08-07

Similar Documents

Publication Publication Date Title
Majid et al. Ipomoea batatas L. Lam. ameliorates acute and chronic inflammations by suppressing inflammatory mediators, a comprehensive exploration using in vitro and in vivo models
CN101485655B (zh) 二氢杨梅素在制备防治肿瘤放化疗不良反应的药物的应用
Dandapat et al. Secondary metabolites from lichen Usnea longissima and its pharmacological relevance
EP2623111A2 (en) Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition
CN110464727B (zh) 3,4-二氢-2h-苯并-[1,4]恶嗪类药物或其盐在制备抑制铁死亡药物中的应用
CN112409439B (zh) 一种甘草酸衍生物、制备方法及应用
Nongalleima et al. Citrus macroptera Montruz extracts
Mazzolin et al. Antidiarrheal and intestinal antiinflammatory activities of a methanolic extract of Qualea parviflora Mart. in experimental models
Ojeswi et al. Protective effect of Thuja occidentalis against DMBA-induced breast cancer with reference to oxidative stress
CN104027362B (zh) 用于治疗肺癌的牛樟芝萃取物及其制备方法
Li et al. The double face of licorice-kansui herb pair: Cure or curse, depending on the combining ratio and mediated by hydrogen sulfide
CN106220643A (zh) 灵芝内酯d及其药物组合物与其在制药和食品中的应用
Singh et al. Antiallergic/antiasthmatic activity of oligopeptide related to IgE
Chandrappa et al. In vitro anti-inflammatory activity of Carmona retusa (Vahl.)
Ukwueze et al. An evaluation of the analgesic and anti-inflammatory activities of the solvent fractions of Aspilia africana (pers.)
Alshahrani et al. Effects of Commiphora myrrha resin extract/nanosilver on immune cells, pathogen, and breast/colon cancer cell line growth
CN101485791B (zh) 显齿蛇葡萄总黄酮在制备防治肿瘤放化疗不良反应的药物的应用
JP5231244B2 (ja) 胃炎または胃潰瘍の予防及び治療に有用なモクベツシ抽出物及びこれから分離されたモモルディカ・サポニンｉ
Indrawati et al. The Effect of an Annona muricata Leaves Extract on Circulating Soluble Adhesion Molecules in Colon Carcinogenesis Model
JP5995235B2 (ja) シガテラを治療するためのロスマリン酸及びその誘導体の使用
US20250360100A1 (en) Anti-cancer derivatives of ovatodiolide and use thereof
CN121248596A (zh) 一种α-硫辛酸吩噻嗪衍生物及其制备方法与应用
WO2012093919A2 (ko) 백혈병 치료용 조성물 및 몰약 추출물의 제조방법
Ekutsu et al. Orapuh Journal
HK1187261A (en) Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application